Max Healthcare to Invest $450 Million in India’s Health System

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Endo Announces Peyronie’s Disease Presentation at...

Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today...

Leadership at NHS Hospitals in Leeds...

A watchdog has gone on to say that the...

Developing Dr. CaBot, A Medical Education...

Harvard Medical School researchers are developing Dr. CaBot as...

UK & U.S. Regulators Partner for...

The medicines regulator of the UK has announced plans...

Max Healthcare plans to invest $450 million in the next four years to add capacity to India’s health care system as the Covid-19 pandemic hit it. “We want to double our capacity in cities like Mumbai and New Delhi,” Abhay Soi, Chairman and Managing Director of Max Healthcare.

The investment will boost capacity at existing hospitals and increase the firm’s landholdings. Max Healthcare will continue focusing on medical tourism. The expansion plans came after the pandemic as a country with around 1.4 billion people who suffered due to the healthcare system. The corona wave in April and May flooded hospitals and left many Indian citizens pleading for medical resources.

Indian hospitals and the government said that the pandemic has led to improvements in the health care system, with many facilities like oxygen plants switching rapidly between Covid medical care and non-Covid treatments during the next Covid-19 wave.

Latest stories

Related stories

Developing Dr. CaBot, A Medical Education Tool That Reasons

Harvard Medical School researchers are developing Dr. CaBot as...

UK & U.S. Regulators Partner for Medtech Regulatory Reforms

The medicines regulator of the UK has announced plans...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »